Below are the earnings highlights for Ligand Pharmaceuticals Inc (LGND):
-Net Income: $38.48 Mln in Q2 vs. $5.17 Mln in the same period last year.
-EPS: $1.81 in Q2 vs. $0.24 in the same period last year.
-Analysts projected $0.40 per share
-Revenue: $18.42 Mln in Q2 vs. $10.61 Mln in the same period last year.
-Guidance:
Full year EPS guidance: $3.45 - $3.50
Full year revenue guidance: $81.0 - $83.0 Mln
For comments and feedback contact: editorial@rttnews.com